Simon F De Meyer Selected Research

agkicetin

4/2005

How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon F De Meyer Research Topics

Disease

29	Thrombosis (Thrombus) 08/2022 - 08/2008
17	Ischemic Stroke 04/2021 - 04/2009
16	Thrombotic Thrombocytopenic Purpura 11/2021 - 03/2014
13	Stroke (Strokes) 01/2022 - 04/2009
5	Reperfusion Injury 01/2021 - 08/2012
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 10/2010
5	Hemorrhage 02/2015 - 06/2006
4	Thrombocytopenia (Thrombopenia) 01/2017 - 04/2005
3	Brain Ischemia (Cerebral Ischemia) 01/2021 - 08/2012
3	Vascular System Injuries 01/2019 - 07/2011
3	von Willebrand Diseases (von Willebrand's Disease) 10/2018 - 06/2006
3	Thrombotic Microangiopathies 01/2016 - 03/2014
3	Pathologic Constriction (Stenosis) 08/2012 - 12/2007
2	Malaria 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2018
2	Hemolytic Anemia 01/2017 - 11/2015
2	acquired Thrombotic thrombocytopenic purpura 01/2016 - 11/2015
2	Cerebral Infarction 01/2016 - 10/2015
2	Infarction (Infarctions) 01/2016 - 08/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2014 - 12/2012
2	Hypoxia (Hypoxemia) 09/2013 - 08/2012
2	Venous Thrombosis (Deep-Vein Thrombosis) 08/2012 - 01/2011
1	Breakthrough Infections 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Calcinosis 02/2021
1	Thromboinflammation 01/2021
1	Infections 01/2020
1	Cerebral Malaria 01/2020
1	Sepsis (Septicemia) 01/2020
1	Edema (Dropsy) 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	deficiency Von willebrand factor 11/2018
1	Abdominal Aortic Aneurysm 11/2018
1	Rare Diseases (Rare Disease) 11/2018
1	Type 2 von Willebrand Disease 10/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018
1	Transfusion-Related Acute Lung Injury 07/2015
1	Thromboembolism 02/2015
1	Ischemia 01/2014
1	Status Epilepticus (Complex Partial Status Epilepticus) 09/2013

Drug/Important Bio-Agent (IBA)

30	von Willebrand FactorIBA 11/2021 - 06/2006
10	AutoantibodiesIBA 11/2021 - 01/2016
8	FibrinIBA 01/2022 - 02/2015
8	Metalloproteases (Metalloproteinases)IBA 01/2021 - 01/2016
7	DisintegrinsIBA 01/2021 - 01/2016
7	ThrombospondinsIBA 01/2021 - 01/2016
7	Glycoproteins (Glycoprotein)IBA 01/2019 - 04/2009
6	AntibodiesIBA 01/2020 - 03/2014
6	thiamine triphosphorate (TTP)IBA 01/2018 - 11/2015
5	CollagenIBA 01/2017 - 12/2007
4	DNA (Deoxyribonucleic Acid)IBA 02/2021 - 08/2012
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2018
3	ChromatinIBA 02/2019 - 08/2012
3	Platelet Membrane GlycoproteinsIBA 01/2019 - 09/2011
2	EpitopesIBA 07/2020 - 10/2018
2	EnzymesIBA 07/2020 - 01/2018
2	Hemostatics (Antihemorrhagics)IBA 01/2019 - 07/2011
2	Pharmaceutical PreparationsIBA 01/2018 - 03/2009
2	Histones (Histone)IBA 08/2017 - 08/2012
2	ADAMTS13 ProteinIBA 01/2017 - 01/2017
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2016 - 03/2014
2	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2016 - 02/2015
2	estropipate (Ogen)FDA LinkGeneric 01/2016 - 10/2015
2	Plasminogen Activator Inhibitor 1IBA 01/2016 - 02/2015
2	Fibrinolysin FDA Link 01/2015 - 03/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2012 - 08/2008
1	BNT162 VaccineIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 02/2021
1	Coloring Agents (Dyes)IBA 02/2021
1	Feulgen stainIBA 02/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2021
1	SuspensionsIBA 01/2021
1	AntigensIBA 01/2020
1	CytokinesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 01/2019
1	Angiotensin IIIBA 11/2018
1	MorpholinosIBA 07/2018
1	Inosine Triphosphate (ITP)IBA 01/2018
1	Deoxyribonucleases (DNase)FDA Link 08/2017
1	Leukocyte Elastase (Neutrophil Elastase)IBA 08/2017
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2017
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2016
1	Member 2 Protein Solute Carrier Family 44IBA 07/2015
1	Thrombin FDA Link 02/2015
1	Thromboplastin (Tissue Factor)IBA 02/2015
1	Streptokinase FDA Link 03/2014
1	Pilocarpine (Ocusert)FDA LinkGeneric 09/2013

Therapy/Procedure

8	Thrombectomy 08/2022 - 11/2018
6	Therapeutics 01/2020 - 02/2012
2	Transplantation 10/2015 - 12/2009
1	Extracorporeal Membrane Oxygenation 01/2022
1	Oxygenators 01/2022
1	Endovascular Procedures 11/2021
1	Heart-Assist Devices 10/2018
1	Secondary Prevention 01/2017